Terasaki Fumio, Kusano Kengo, Nakajima Takatomo, Yazaki Yoshikazu, Morimoto Shin-Ichiro, Culver Daniel A, Isobe Mitsuaki
Medical Education Center/Department of Cardiology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Authors contributed equally to this article.
Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(3):e2022028. doi: 10.36141/svdld.v39i3.12531. Epub 2022 Sep 23.
Sarcoidosis in Japanese sarcoidosis is characterized by a high prevalence of cardiac involvement. In this regard, cardiac sarcoidosis (CS) continues to be an important focus of study among physicians caring for sarcoidosis in Japan. The Japanese Ministry of Health, Labor and Welfare (MHLW) and Japan Society of Sarcoidosis and other Granulomatous Disorders (JSSOG) have published clinical guidelines aiming to assist clinical practices. Recently, the Japanese Circulation Society (JCS) has published new clinical guidelines for the diagnosis and treatment of CS that contain several new insights compared to previously published guidelines in Japan and other countries.
日本结节病的特点是心脏受累的患病率很高。在这方面,心脏结节病(CS)仍然是日本治疗结节病的医生们重要的研究重点。日本厚生劳动省(MHLW)和日本结节病及其他肉芽肿性疾病协会(JSSOG)已经发布了旨在协助临床实践的临床指南。最近,日本循环学会(JCS)发布了CS诊断和治疗的新临床指南,与日本和其他国家之前发布的指南相比,其中包含了一些新的见解。